A Study of Adjuvant V940 and Pembrolizumab in Renal Cell Carcinoma (V940-004) – Full Text View – ClinicalTrials.gov
A Study of Adjuvant V940 and Pembrolizumab in Renal Cell Carcinoma (V940-004) – Full Text View.
A Study of Adjuvant V940 and Pembrolizumab in Renal Cell Carcinoma (V940-004) – Full Text View.
This is among the few studies specifically examining outcomes of patients with critical limb ischemia and ESKD receiving dialysis.
“Certainly, there are more and more radioligands coming out not only in prostate cancer, but in other cancers related to urology, and I think that’s…
Findings independent of diabetes duration over a 10-year period
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t…
The European Association of Urology (EAU) Renal Transplantation Guidelines aim to provide a comprehensive overview of the medical and technical aspects relating to renal transplantation.
The potential effects of alpha-blockers on prostate cancer development and death have been debated.
Plenary Session 1 After delegates were welcomed by representatives from …
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Read our Cookies
“When we looked at the risk of bleeding and takeback for fulguration, the reported rate was 0.46%. Less than 1% of patients had any significant…
Even in the United States, women with chronic kidney disease (CKD) are receiving less than optimal care.